Impaired Physical Performance in X-linked Hypophosphatemia is not caused by depleted muscular phosphate stores.


CONTEXT: X-linked hypophosphatemia (XLH) is a rare genetic disease, characterized by renal phosphate wasting and complex musculoskeletal manifestations including decreased physical performance. OBJECTIVE: To characterize muscular deficits in XLH patients and investigate phosphate stores of the muscle. DESIGN: Case-control study (MuXLiH) with a one-time assessment at the German Aerospace Center (DLR), Cologne, from May to December 2019. SETTING: XLH patients cared for at the Osteology Department, University of Wuerzburg. PATIENTS AND PARTICIPANTS: 13 XLH patients and 13 age/sex/body weight matched controls aged 18 to 65 years. MAIN OUTCOME MEASURES: 31P magnetic resonance spectroscopy (31P-MRS) based assessment of phosphate metabolites in the soleus muscle at rest. Further analyses included MRI-based muscle volume measurement, laboratory testing, isokinetic maximum voluntary contraction (MVC), fatigue testing and jumping mechanography. RESULTS: By means of 31P-MRS, no significant differences were observed between XLH and controls regarding phosphate metabolites except for a slightly increased phosphocreatine to inorganic phosphate (PCr/Pi) ratio (XLH: 13.44 +/- 3.22, control: 11.01 +/- 2.62, p = 0.023). Quadriceps muscle volume was reduced in XLH (XLH: 812.1 +/- 309.0 ml, control: 1391.1 +/- 306.2 mv, p < 0.001). No significant differences were observed regarding isokinetic maximum torque (MVC) adjusted to quadriceps muscle volume. Jumping peak power and jump height were significantly reduced in XLH vs. controls (both p < 0.001). CONCLUSION: The content of phosphoric compounds within the musculature of XLH patients was not observed to be different from controls. Volume-adjusted muscle strength and fatiguability were not different, either. Reduced physical performance in XLH patients may result from long-term adaptation to reduced physical activity due to skeletal impairment.

Autor: Kara JAS, Zange J, Hoffman F, Tank J, Jordan J, Semler O, Schonau E, Rittweger J, Seefried L

Organisation: German Aerospace Center, Institute of Aerospace Medicine, Linder Hohe, 51147 Cologne, Germany.

Jahr: 2023

GID: 5962

Erstellt am: 25.04.2023

Das Urteil unserer Kunden: Hervorragend


4,7 von 5 Sternen basierend auf 868 Bewertungen

TÜV zertifiziert

Wir sind vom TÜV zertifizierter Hersteller für Medizinprodukte.

Made in Germany

Die Entwicklung und Herstellung findet nur in Deutschland statt.

Bewährte Qualität

10 Jahre Servicegarantie & mehr als 35 Jahre Erfahrung im Firmenverbund.


Über 2000 wissenschaftliche Publikationen zu unseren Produkten.

Weltweit Tätig

Mit unseren Vertriebspartnern international tätig.

Fangen Sie an zu tippen, um die gesuchten Beiträge zu sehen.